Design of protein-releasing chitosan channels

Biotechnology Progress

Volumn 24, Issue 4, 2008, Pages 932-937

  Kim, Howard ^a,b   Tator, Charles H ^a,c   Shoichet, Molly S ^b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; CHITIN; CHITOSAN; CLADDING (COATING); CONTROLLED DRUG DELIVERY; DOSIMETRY; DRUG DELIVERY; DRUG DOSAGE; HEALTH; MICROSPHERES; SPIN COATING;

ACIDIC SOLUTIONS; ALKALINE PHOSPHATASE; AXONAL REGENERATION; IN-SITU; NEURAL TISSUES; PLGA MICROSPHERES; POLY-LACTIDE-CO-GLYCOLIDE; SPIN COATINGS; SPINAL CORDS; SUSTAINED DRUG RELEASE; TRAUMATIC INJURIES; WALL THICKNESSES;

AMINES;

CHITOSAN; DRUG CARRIER; POLYGLACTIN;

CHEMISTRY; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; EVALUATION; HUMAN; INSTRUMENTATION; METHODOLOGY; SPINAL CORD INJURY;

CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; POLYGLACTIN 910; SPINAL CORD INJURIES;

EID: 51849167277     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp.070352a     Document Type: Conference Paper

References (52)

1. Tator CH. Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. Neurosurgery. 2006;59:957-982; discussion 982-987.
2. Bertleff MJ, Meek MF, Nicolai JP. A prospective clinical evaluation of biodegradable neurolac nerve guides for sensory nerve repair in the hand. J HandSurg. 2005;30:513-518.
3. Navissano M, Malan F, Carnino R, Battiston B Neurotube for facial nerve repair. Microsurgery. 2005;25:268-271.
4. Tsai EC, Dalton PD, Shoichet MS, Tator CH. Synthetic hydrogel guidance channels facilitate regeneration of adult rat brainstem motor axons after complete spinal cord transection. J Neurotrauma. 2004;21:789-804.
5. Tsai EC, Dalton PD, Shoichet MS, Tator CH. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials. 2006;27:519-533.
6. Oudega M, Gautier SE, Chapon P, Fragoso M, Bates ML, Parel JM, Bunge MB. Axonal regeneration into Schwann cell grafts within resorbable poly(alpha-hydroxyacid) guidance channels in the adult rat spinal cord. Biomaterials. 2001;22:1125-1136.
7. Xu XM, Guenard V, Kleitman N, Bunge MB. Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol. 1995;351:145-160.
8. Zahir T, Nomura H, Guo XD, Kim H, Tator CH, Morshead CM, Shoichet MS. Bioengineering neural stem/progenitor cell-coated tubes for spinal cord injury repair. Cell Transplant. In press.
9. Kwon BK, Liu J, Lam C, Plunet W, Oschipok LW, Hauswirth W, Di Polo A, Blesch A, Tetzlaff W. Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury. Spine. 2007;32:1164-1173.
10. Zhou L, Baumgartner BJ, Hill-Felberg SJ, McGowen LR, Shine HD. Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J Neurosci. 2003;23:1424-1431.
11. Namiki J, Kojima A, Tator CH. Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats. J Neurotrauma. 2000;17:1219-1231.
12. Liebscher T, Schnell L, Schnell D, Scholl J, Schneider R, Gullo M, Fouad K, Mir A, Rausch M, Kindler D, Hamers FP, Schwab ME. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol. 2005;58:706-719.
13. Wang X, Baughman KW, Basso DM, Strittmatter SM. Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann Neurol. 2006;60:540-549.
14. Monnier PP, Sierra A, Schwab JM, Henke-Fahle S, Mueller BK. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteogly-cans of the CNS glial scar. Mol Cell Neurosci. 2003;22:319-330.
15. Barritt AW, Davies M, Marchand F, Hartley R, Grist J, Yip P, McMahon SB, Bradbury EJ. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci. 2006;26:10856-10867.
16. Motta F, Buonaguro V, Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg. 2007; 107(1 Suppl):32-35.
17. Protopapas MG, Bundock E, Westmoreland S, Nero C, Graham WA, Nesathurai S. The complications of scar formation associated with intrathecal pump placement. Arch Phys Med Rehabil. 2007;88:389-390.
18. Midha R, Munro CA, Dalton PD, Tator CH, Shoichet MS. Growth factor enhancement of peripheral nerve regeneration through a novel synthetic hydrogel tube. J Neurosurg. 2003;99: 555-565.
19. Hadlock T, Sundback C, Koka R, Hunter D, Cheney M, Vacanti J. A novel, biodegradable polymer conduit delivers neurotrophins and promotes nerve regeneration. Laryngoscope. 1999; 109:1412-1416.
20. Aebischer P, Salessiotis AN, Winn SR. Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps. J Neurosci Res. 1989;23:282-289.
21. Bloch J, Fine EG, Bouche N, Zurn AD, Aebischer P. Nerve growth factor- and neurotrophin-3-releasing guidance channels promote regeneration of the transected rat dorsal root. Exp Neurol. 2001;172:425-432.
22. Barras FM, Pasche P, Bouche N, Aebischer P, Zurn AD. Glial cell line-derived neurotrophic factor released by synthetic guidance channels promotes facial nerve regeneration in the rat. J Neurosci Res. 2002;70:746-755.
23. Piotrowicz A, Shoichet MS. Nerve guidance channels as drug delivery vehicles. Biomaterials. 2006;27:2018-2027.
24. Yang Y, De Laporte L, Rives CB, Jang JH, Lin WC, Shull KR, Shea LD. Neurotrophin releasing single and multiple lumen nerve conduits. J Controlled Release. 2005;104:433-446.
25. Goraltchouk A, Scanga V, Morshead CM, Shoichet MS. Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release. J Controlled Release. 2006;110:400-407.
26. Nomura H, Katayama Y, Shoichet MS, Tatar CH. Complete spinal cord transection treated by implantation of a reinforced synthetic hydrogel channel results in syringomyelia and caudal migration of the rostral stump. Neurosurgery. 2006;59:183-192; discussion 183-192.
27. Freier T, Montenegro R, Shan Koh H, Shoichet MS. Chitin- based tubes for tissue engineering in the nervous system. Biomaterials. 2005;26:4624-4632.
28. Freier T, Koh HS, Kazazian K, Shoichet MS. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials. 2005;26:5872-5878.
29. Lavertu M, Xia Z, Serreqi AN, Berrada M, Rodrigues A, Wang D, Buschmann MD, Gupta A. A validated 1H NMR method for the determination of the degree of deacetylation of chitosan. J Pharm Biomed Anal. 2003;32:1149-1158.
30. Aubert-Pouessel A, Bibby DC, Venier-Julienne MC, Hindre F, Benoit JP. A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres. Pharm Res. 2002;19:1046-1051.
31. Dorati R, Genta I, Montanari L, Cilurzo F, Buttafava A, Faucitano A, Conti B. The effect of gamma-irradiation on PLGA/ PEG microspheres containing ovalbumin. J Controlled Release. 2005;107:78-90.
32. Ruhe PQ, Boerman OC, Russel FG, Spauwen PH, Mikos AG, Jansen JA. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Controlled Release. 2005;106:162-171.
33. Srinivasan C, Katare YK, Muthukumaran T, Panda A. K. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles. J Microencapsulation. 2005;22:127-138.
34. Pean JM, Venier-Julienne MC, Boury F, Menei P, Denizot B, Benoit JP. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. J Controlled Release. 1998;56:175-187.
35. Jollivet C, Aubert-Pouessel A, Clavreul A, Venier-Julienne MC, Remy S, Montero-Menei CN, Benoit JP, Menei P. Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease. Biomaterials. 2004;25:933-942.
36. Kang F, Singh J. Effect of additives on the release of a model protein from PLGA microspheres. AAPS Pharm Sci Tech. 2001;2:30.
37. Rizkalla N, Range C, Lacasse FX, Hildgen P. Effect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion method. J Microencapsulation. 2006;23:39-57.
38. 3 as additives on the enzymatic activity of carbonic anhydrase encapsulated in poly(lactide-co-glycolide) (PLGA) microspheres. Biochim Biophys Acta. 2002;1570:63-74.
39. Jiang G, Thanoo BC, DeLuca PP. Effect of osmotic pressure in the solvent extraction phase on BSA release profile from PLGA microspheres. Pharm Dev Technol. 2002;7:391-399.
40. Estey T, Kang J, Schwendeman SP, Carpenter JF. BSA degradation under acidic conditions: A model for protein instability during release from PLGA delivery systems. J Pharm Sci. 2006;95:1626-1639.
41. Bhatti AR, Alvi A, Walia S, Chaudhry GR. pH-dependent modulation of alkaline phosphatase activity in Serratia marcescens. Curr Microbiol. 2002;45:245-249.
42. Faisant N, Akiki J, Siepmann F, Benoit JP, Siepmann J. Effects of the type of release medium on drug release from PLGA- based microparticles: experiment and theory. Int J Pharm. 2006; 314:189-197.
43. Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Controlled Release. 2007;122:338-344.
44. Husmann M, Schenderlein S, Luck M, Lindner H, Kleinebudde P. Polymer erosion in PLGA microparticles produced by phase separation method. Int J Pharm. 2002;242:277-280.
45. Chung TW, Tsai YL, Hsieh JH, Tsai WJ. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. J Microencapsulation. 2006;23:15-27.
46. Mittal G, Sahana DK, Bhardwaj V, Ravi, Kumar MN. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Controlled Release. 2007;119:77-85.
47. Cao X, Shoichet MS. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials. 1999;20:329-339.
48. Berchane NS, Carson KH, Rice-Ficht AC, Andrews MJ. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory. Int J Pharm. 2007;337: 118-126.
49. Yeh MK, Tung SM, Lu DW, Chen JL, Chiang CH. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles. J Microencapsulation. 2001;18:507-519.
50. Sanchez A, Tobio M, Gonzalez L, Fabra A, Alonso MJ. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci. 2003;18:221-229.
51. Kang SW, Cho ER, Jeon O, Kim BS. The effect of microsphere degradation rate on the efficacy of polymeric microspheres as bulking agents: an 18-month follow-up study. J Biomed Mater Res, Part B. 2007;80:253-259.
52. Zhu G, Schwendeman SP. Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives. Pharm Res. 2000;17:351-357.